GLP-3 Retatrutide – 5mg | 10mg | 20mg | 40mg
GLP-3 Retatrutide – 5mg | 10mg | 20mg | 40mg
Price range: $125.00 through $1,800.00
5/10/15/20 mg per vial
- This product is prepared for PRESCRIBER USE ONLY and may not be used for other purposes.
FREE & FAST SHIPPING
PUREST QUALITY
EXCELLENT SERVICE
Properties
| Molecular Formula | C221H342N46O68 |
|---|---|
| Molecular Weight | 4845.444 |
| Monoisotopic Mass | |
| Polar Area | |
| Complexity | |
| XLogP | |
| Heavy Atom Count | |
| Hydrogen Bond Donor Count | |
| Hydrogen Bond Acceptor Count | |
| Rotatable Bond Count | |
| Physical Appearance | Fine White Lyophilized Powder |
| Stability | Lyophilized protein is to be stored at -20°C. It is recommended to aliquot the reconstituted (dissolved) protein into several discrete vials in order to avoid repeated freezing and thawing. Reconstituted protein can be stored at 4°C |
| PubChem LCSS |
Identifiers
| CID | |
|---|---|
| CAS | 2381089-83-2 |
| InChI | |
| InChIKey | |
| Isomeric SMILES | |
| Canonical SMILES | |
| IUPAC Name |
Description
GLP-3 Retatrutide
Product is sold for prescriber purposes only. Please handle with care and follow all safety guidelines for the specific chemicals involved.
GLP-3 Retatrutide is a novel investigational peptide being explored for its potential therapeutic benefits in metabolic disorders, particularly obesity and type 2 diabetes. It is a multi-receptor agonist that targets multiple pathways involved in glucose and energy homeostasis. Here’s a detailed description of retatrutide for research purposes:
Preclinical and Clinical Research
- Animal Studies: Preclinical studies in rodent and non-human primate models have shown that retatrutide effectively reduces body weight, improves insulin sensitivity, and lowers blood glucose levels. These studies also indicate beneficial effects on lipid metabolism and liver fat reduction.
- Clinical Trials: Early-phase clinical trials have demonstrated promising results in humans, with significant weight loss and improved glycemic control observed in participants. Ongoing trials are focused on optimizing dosing regimens and further evaluating the safety and efficacy profile
Conclusion
GLP-3 RT represents a promising multi-receptor agonist peptide for treating metabolic disorders, particularly obesity and type 2 diabetes. Its comprehensive approach to enhancing glycemic control and promoting weight loss through GLP-1, glucagon, and GIP receptor activation makes it a valuable subject of ongoing research. Continued studies are essential to fully understand its therapeutic potential and safety profile, paving the way for potential clinical applications in managing metabolic diseases.
Reference:
ALL LITERATURE, INFORMATION, AND DATA, PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY.
Accurate research is our number one priority.
Same Day Shipping
Enjoy the convenience of receiving your order swiftly. We offer same-day shipping on all orders of in-stock items placed before 12:00 pm EST.
Dedicated Service
Our dedicated team is always at your service, Ready to assist you with any customer service requests you may have. We prioritize your satisfaction and aim to provide a seamless experience.
Free Shipping
To enhance your shopping experience, We offer free shipping on all orders totaling $200 or more. Rest assured, we've got you covered!
Purist Quality
We take pride in ensuring the utmost purity of our products. Every item we offer undergoes rigorous lab testing and is certified for the highest possible purity.
